OUR MISSION

Our mission is to turn cutting-edge science into life-saving therapeutics

To achieve our mission, we are committed to building an innovative, values-driven organization focused on our people, the advancement of our efficient drug platform and the creation of a deep pipeline of therapeutics to address intractable diseases. 

Research Focus

The Platform and
Disease Areas

adarx-research-focus

The Platform that ADARx is developing

ADARx is developing a modality agnostic RNA targeting platform, including oligonucleotides for inhibition, degradation and editing, together with novel oligonucleotide delivery technologies.

adarx-research-focus-2

Disease areas that ADARx is targeting

ADARx is currently focused on diseases in three therapeutic areas: genetic diseases, cardiometabolic diseases, and central nervous system (CNS) diseases.

adarx-research-focus

Future Research Focus

With RNA as the target of our drug discovery, we are capable of working on a wide range of diseases and will continue to add additional disease targets to our pipeline in areas of unmet medical need.

ADARx brings hope for people with intractable disease